Revelation Biosciences Warrant
REVBW
18 hedge funds and large institutions have $3.69M invested in Revelation Biosciences Warrant in 2021 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 3 increasing their positions, 2 reducing their positions, and 4 closing their positions.
50% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 2
25% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 4
6% more funds holding
Funds holding: 17 → 18 (+1)
40% less capital invested
Capital invested by funds: $6.18M → $3.69M (-$2.49M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GCL
Glazer Capital LLC
New York
|
+$336K |
| 2 |
OCAM
Owl Creek Asset Management
New York
|
+$182K |
| 3 |
Capstone Investment Advisors
New York
|
+$55.7K |
| 4 |
TI
Telemetry Investments
New York
|
+$49K |
| 5 |
EPM
Equitec Proprietary Markets
Chicago,
Illinois
|
+$24.2K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ASM
ATW SPAC Management
New York
|
-$2.18M |
| 2 |
BFM
Boothbay Fund Management
New York
|
-$131K |
| 3 |
EAM
Exos Asset Management
New York
|
-$12K |
| 4 |
PAM
Panagora Asset Management
Boston,
Massachusetts
|
-$3K |
| 5 |
Jane Street
New York
|
-$2.42K |
REVBW Hedge Fund Activity: Q3 2021 in Review
18 of the 5,728 institutional investors tracked by Wall St. Rank reported a position in Revelation Biosciences Warrant (REVBW) for Q3 2021, worth a combined $3.69M — down 40% from $6.18M a quarter earlier.
Buyers outnumbered sellers: 5 funds opened new REVBW positions and 4 closed out — a net gain of 1 holder — while 3 added to existing stakes and 2 trimmed.
The largest buyer was Glazer Capital LLC, opening a new position worth an estimated $336K. The largest seller was ATW SPAC Management, exiting entirely with an estimated $2.18M sold.
- 18 institutional investors held Revelation Biosciences Warrant (REVBW) as of Q3 2021, up from 17 in Q2 2021.
- Funds reported $3.69M of Revelation Biosciences Warrant stock for Q3 2021, down 40% quarter-over-quarter.
- 5 funds opened new Revelation Biosciences Warrant positions in Q3 2021 and 4 closed out, a net change of +1 holder.
- The largest Revelation Biosciences Warrant buyer in Q3 2021 was Glazer Capital LLC, an estimated $336K added.
- The largest Revelation Biosciences Warrant seller in Q3 2021 was ATW SPAC Management, an estimated $2.18M sold.
Based on aggregated 13F filings for Q3 2021.